These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
654 related items for PubMed ID: 26744892
1. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. Littera R, Chessa L, Onali S, Figorilli F, Lai S, Secci L, La Nasa G, Caocci G, Arras M, Melis M, Cappellini S, Balestrieri C, Serra G, Conti M, Zolfino T, Casale M, Casu S, Pasetto MC, Barca L, Salustro C, Matta L, Scioscia R, Zamboni F, Faa G, Orrù S, Carcassi C. PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892 [Abstract] [Full Text] [Related]
2. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation. Littera R, Piredda G, Argiolas D, Lai S, Congeddu E, Ragatzu P, Melis M, Carta E, Michittu MB, Valentini D, Cappai L, Porcella R, Alba F, Serra M, Loi V, Maddi R, Orrù S, La Nasa G, Caocci G, Cusano R, Arras M, Frongia M, Pani A, Carcassi C. PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681 [Abstract] [Full Text] [Related]
3. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes. Hilton HG, Guethlein LA, Goyos A, Nemat-Gorgani N, Bushnell DA, Norman PJ, Parham P. J Immunol; 2015 Oct 01; 195(7):3160-70. PubMed ID: 26311903 [Abstract] [Full Text] [Related]
4. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury. Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A. Transplantation; 2013 Apr 27; 95(8):1037-44. PubMed ID: 23478359 [Abstract] [Full Text] [Related]
5. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A. Int J Immunogenet; 2011 Oct 27; 38(5):403-9. PubMed ID: 21797986 [Abstract] [Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F. Liver Transpl; 2009 Apr 27; 15(4):390-9. PubMed ID: 19326408 [Abstract] [Full Text] [Related]
7. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M. Cancer Immunol Immunother; 2005 Feb 27; 54(2):172-8. PubMed ID: 15248031 [Abstract] [Full Text] [Related]
8. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. J Hepatol; 2007 May 27; 46(5):899-906. PubMed ID: 17383044 [Abstract] [Full Text] [Related]
9. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer. Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I, Grzybowska E. Hum Immunol; 2014 Jun 27; 75(6):508-13. PubMed ID: 24755350 [Abstract] [Full Text] [Related]
10. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis. Mahmoudi M, Fallahian F, Sobhani S, Ghoroghi S, Jamshidi A, Poursani S, Dolati M, Hosseinpour Z, Gharibdoost F. Clin Rheumatol; 2017 Apr 27; 36(4):853-862. PubMed ID: 28120169 [Abstract] [Full Text] [Related]
11. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection. Littera R, Chessa L, Deidda S, Angioni G, Campagna M, Lai S, Melis M, Cipri S, Firinu D, Santus S, Lai A, Porcella R, Rassu S, Meloni F, Schirru D, Cordeddu W, Kowalik MA, Ragatzu P, Vacca M, Cannas F, Alba F, Carta MG, Del Giacco S, Restivo A, Deidda S, Palimodde A, Congera P, Perra R, Orrù G, Pes F, Loi M, Murru C, Urru E, Onali S, Coghe F, Giglio S, Perra A. PLoS One; 2021 Apr 27; 16(8):e0255608. PubMed ID: 34352002 [Abstract] [Full Text] [Related]
12. Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients. Cosentini E, Gargiulo L, Bruno P, Lastraioli S, Risitano A, Camerlingo R, Luongo V, Serra M, Sica M, Garzillo C, Giani U, Notaro R, Alfinito F, Ruggiero G, Terrazzano G. Tissue Antigens; 2012 Oct 27; 80(4):322-7. PubMed ID: 22803950 [Abstract] [Full Text] [Related]
13. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK. Gastroenterology; 2019 Oct 27; 157(4):1067-1080.e9. PubMed ID: 31229495 [Abstract] [Full Text] [Related]
14. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals. Legrand N, David G, Rodallec A, Gaultier A, Salmon D, Cesbron A, Wittkop L, Raffi F, Gendzekhadze K, Retière C, Allavena C, Gagne K. Clin Exp Immunol; 2021 Apr 27; 204(1):107-124. PubMed ID: 33314121 [Abstract] [Full Text] [Related]
15. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection. Mele D, Pasi A, Cacciatore R, Mantovani S, Oliviero B, Mondelli MU, Varchetta S. Liver Int; 2019 Jul 27; 39(7):1237-1245. PubMed ID: 31177636 [Abstract] [Full Text] [Related]
17. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. Di Bona D, Aiello A, Colomba C, Bilancia M, Accardi G, Rubino R, Giannitrapani L, Tuttolomondo A, Cascio A, Caiaffa MF, Rizzo S, Di Lorenzo G, Candore G, Duro G, Macchia L, Montalto G, Caruso C, KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative GroupDipartimento di Biopatologia e Biotecnologie Mediche, Università di Palermo, Palermo, Italy.Unità Operativa di Medicina Trasfusionale, AOUP, Palermo, Italy.. J Viral Hepat; 2017 Sep 27; 24(9):768-775. PubMed ID: 28211154 [Abstract] [Full Text] [Related]
18. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population. Auer ED, Tong HV, Amorim LM, Malheiros D, Hoan NX, Issler HC, Petzl-Erler ML, Beltrame MH, Boldt ABW, Toan NL, Song LH, Velavan TP, Augusto DG. Int J Infect Dis; 2020 Jul 27; 96():541-547. PubMed ID: 32422377 [Abstract] [Full Text] [Related]